Prolymphocytic leukemia, a rare cancer, typically has a poor prognosis. This case study shows combination chemotherapy and splenectomy can significantly prolong survival in prolymphocytic leukemia patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: